Permeation Protection by Waterproofing Mucosal Membranes.

kinetic permeation mucosa permeability protection

Journal

Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003

Informations de publication

Date de publication:
29 Nov 2023
Historique:
received: 19 10 2023
revised: 24 11 2023
accepted: 27 11 2023
medline: 23 12 2023
pubmed: 23 12 2023
entrez: 23 12 2023
Statut: epublish

Résumé

The permeability of the oral or nasal mucosa is higher than that of the skin. Mucosa permeability depends mainly on the thickness and keratinization degree of the tissues. Their permeability barrier is conditioned by the presence of certain lipids. This work has the main aim of reinforcing the barrier effect of oral mucosa with a series of formulations to reduce permeation. Transmembrane water loss of different formulations was evaluated, and three of them were selected to be tested on the sublingual mucosa permeation of drugs. Caffeine, ibuprofen, dexamethasone, and ivermectin were applied on porcine skin, mucosa, and modified mucosa in order to compare the effectiveness of the formulations. A similar permeation profile was obtained in the different membranes: caffeine > ibuprofen~dexamethasone > ivermectin. The most efficient formulation was a liposomal formulation composed of lipids that are present in the skin stratum corneum. Impermeability provided by this formulation was notable mainly for the low-molecular-weight compounds, decreasing their permeability coefficient by between 40 and 80%. The reinforcement of the barrier function of mucosa provides a reduction or prevention of the permeation of different actives, which could be extrapolated to toxic compounds such as viruses, contaminants, toxins, etc.

Identifiants

pubmed: 38140039
pii: pharmaceutics15122698
doi: 10.3390/pharmaceutics15122698
pii:
doi:

Types de publication

Journal Article

Langues

eng

Auteurs

Luisa Coderch (L)

Surfactants and Nanobiotechnology Department, Institute of Advanced Chemical of Catalonia of CSIC (IQAC-CSIC), Jordi Girona 18-26, 08034 Barcelona, Spain.

Cristina Alonso (C)

Surfactants and Nanobiotechnology Department, Institute of Advanced Chemical of Catalonia of CSIC (IQAC-CSIC), Jordi Girona 18-26, 08034 Barcelona, Spain.

Ana Cristina Calpena (AC)

Department de Farmàcia i Tecnologia Farmacèutica, i Fisicoquímica, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, Avda. Joan XXIII 27-31, 08028 Barcelona, Spain.
Institut de Nanociència i Nanotecnologia UB (IN2UB), Universitat de Barcelona, Avda. Joan XXIII 27-31, 08028 Barcelona, Spain.

Maria Luisa Pérez-García (ML)

Institut de Nanociència i Nanotecnologia UB (IN2UB), Universitat de Barcelona, Avda. Joan XXIII 27-31, 08028 Barcelona, Spain.
Departament de Farmacologia, Toxicologia i Química Terapèutica, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, Avda. Joan XXIII 27-31, 08028 Barcelona, Spain.

Beatriz Clares-Naveros (B)

Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of Granada, 18071 Granada, Spain.
Biosanitary Research Institute of Granada (ibs GRANADA), Avda de Madrid 15, 18012 Granada, Spain.

Anderson Ramos (A)

Surfactants and Nanobiotechnology Department, Institute of Advanced Chemical of Catalonia of CSIC (IQAC-CSIC), Jordi Girona 18-26, 08034 Barcelona, Spain.

Meritxell Martí (M)

Surfactants and Nanobiotechnology Department, Institute of Advanced Chemical of Catalonia of CSIC (IQAC-CSIC), Jordi Girona 18-26, 08034 Barcelona, Spain.

Classifications MeSH